Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid LeukemiaAnne-Marie Daull, Vincent Alcazer, Valérie Dubois et al.|Frontiers in Immunology|2022Cited by 25
Long-term use of liposomal nebulized amikacin and tedizolid for the treatment of disseminated nocardiosis after allogeneic hematopoietic stem cell transplantationSarah Souèges, Martine Wallon, Florence Ader et al.|European Journal of Clinical Microbiology & Infectious Diseases|2021Cited by 10
Distinct Immune Reconstitution Profiles Captured by Immune Functional Assays at 6 Months Post Allogeneic Hematopoietic Stem Cell TransplantationWilliam Mouton, Sophie Trouillet‐Assant, Anne Conrad et al.|Transplantation and Cellular Therapy|2022Cited by 8
Temporal Evolution of Functional Immune Reconstitution after Allogeneic HSCTWilliam Mouton, Anne Conrad, Léa Aguilhon et al.|Transplantation and Cellular Therapy|2025Cited by 7
HLA diversity is associated with TKI response and treatment‐free remission in chronic myeloid leukemiaCharles Toulemonde, Vincent Alcazer, Valérie Dubois et al.|HemaSphere|2025Cited by 2